Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Jr, W, Robinson, BG, Gagel, R, Dralle, H, Fagin, J, Santoro, M, Baudin, E, Elisei, R, Jarzab, B, Vasselli, JR, Read, J, Langmuir, P, Ryan, A, Schlumberger, M
التنسيق:	Journal article
منشور في:	2012

مواد مشابهة

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
حسب: Wells, SA, وآخرون
منشور في: (2012)

Reply to J.-F. Chatal et al.
حسب: Wells Jr, SA, وآخرون
منشور في: (2012)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
حسب: Nils Degrauwe, وآخرون
منشور في: (2012-06-01)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
حسب: Hari Deshpande, وآخرون
منشور في: (2011-01-01)

Calcitonin receptor expression in medullary thyroid carcinoma
حسب: Virginia Cappagli, وآخرون
منشور في: (2017-09-01)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
حسب: Ecem Bostan, وآخرون
منشور في: (2022-09-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
حسب: Fallahi P, وآخرون
منشور في: (2019-08-01)

Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
حسب: А. М. Mudunov, وآخرون
منشور في: (2019-10-01)

CALCITONINS ROLE - REPLY
حسب: Kanis, J, وآخرون
منشور في: (1977)

Metastatic Medullary Thyroid Carcinoma with Normal Serum Calcitonin Levels
حسب: Tania Tofail, MRCP, وآخرون
منشور في: (2018-11-01)

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
حسب: Mijin Kim, وآخرون
منشور في: (2020-09-01)

Serum calcitonin negative Medullary thyroid carcinoma
حسب: Welsing Ellen, وآخرون
منشور في: (2006-12-01)

Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib
حسب: Sravanthi Sanivarapu, MD, وآخرون
منشور في: (2018-09-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
حسب: Ai Matsui, وآخرون
منشور في: (2022-01-01)

In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
حسب: Boultwood, J, وآخرون
منشور في: (1990)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
حسب: Wenliang Yue, وآخرون
منشور في: (2022-11-01)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
حسب: Heymach, J, وآخرون
منشور في: (2008)

Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
حسب: Pierpaolo Trimboli, وآخرون
منشور في: (2018-05-01)

Kinase inhibitors for advanced medullary thyroid carcinoma
حسب: Martin Schlumberger, وآخرون
منشور في: (2012-01-01)

Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin
حسب: Bo Wang, وآخرون
منشور في: (2024-10-01)

The role of calcitonin in the preoperative stage as the predictor of medullary thyroid cancer metastases
حسب: Volodymyr Palamarchuk, وآخرون
منشور في: (2021-12-01)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
حسب: Huguet, I, وآخرون
منشور في: (2013)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
حسب: Clotilde Sparano, وآخرون
منشور في: (2023-02-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
حسب: LI Rui, LIU Zhuoran, YAN Jiqi
منشور في: (2022-06-01)

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
حسب: Fengli Guo, وآخرون
منشور في: (2024-05-01)

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
حسب: Il Youb Jeong, وآخرون
منشور في: (2024-08-01)

The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer
حسب: Yingtong Hou, وآخرون
منشور في: (2024-07-01)

Cytodiagnosis of medullary carcinoma thyroid- role of FNAC and serum calcitonin- A case report
حسب: Majed B Momin, وآخرون
منشور في: (2018-01-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
حسب: Rafael Loch Batista, وآخرون
منشور في: (2013-01-01)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
حسب: Claudio Gambardella, وآخرون
منشور في: (2019-05-01)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
حسب: Hyunju Park, وآخرون
منشور في: (2021-10-01)

Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer
حسب: Samantha M. Siskind, MD, وآخرون
منشور في: (2024-11-01)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
حسب: Zan Jiao, وآخرون
منشور في: (2022-12-01)

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
حسب: Hanrahan, E, وآخرون
منشور في: (2009)

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
حسب: N. V. Severskaya, وآخرون
منشور في: (2022-08-01)

Selective use of vandetanib in the treatment of thyroid cancer
حسب: Fallahi P, وآخرون
منشور في: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
حسب: Kabir, Md Zahirul, وآخرون
منشور في: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
حسب: Abdul Qadir, MPhil, وآخرون
منشور في: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
حسب: Jade Cury-Martins, وآخرون
منشور في: (2018-10-01)

Measurement of calcitonin and cea in the needle washout fluid from thyroid nodule for the diagnosis of medullary thyroid carcinoma
حسب: N. V. Severskaya, وآخرون
منشور في: (2023-11-01)